Trial Profile
Phase I study of mRNA 1850
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 15 Jan 2016
Price :
$35
*
At a glance
- Drugs MRNA 1850 (Primary)
- Indications Bacterial infections; Parasitic infections; Viral infections
- Focus Adverse reactions; First in man
- 15 Jan 2016 New trial record
- 12 Jan 2016 According to Moderna Therapeutics media release, company is planning to initiate this trial in the first quarter of 2016 and the company has also filed an investigational new drug (IND) application with the U.S. Food and Drug Administration (FDA) for mRNA 1850.